15:56 Oct 17
Aurobindo Pharma Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Aurobindo Pharma Ltd.
77/100 High Financial Strength
Quality53/100 Affordable Valuation
Valuation52/100 Technically Neutral
TechnicalSWOT
Strength
8
Weakness
2
Opportunity
0
Threat
3
86.05K
Market Cap (Cr)
24.22
PE Ratio
2.88
Price to Book Ratio
44.65
RSI
10.94 %
Net Profit Margin
Rating Based on 9 Analysts
Buy
33%
Hold
67%
Sell
0%
Hold
Analyst Price Target
The average price target is 1371 with a high estimate of 1785 and low estimate of 1037
Current 1468.65
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation
SWOT
Download Our App On:
